Table: begin end state 1 21 cytoplasmic 22 31 non-cytoplasmic 32 36 transmembrane 37 55 non-cytoplasmic 56 77 transmembrane 78 88 cytoplasmic 89 108 transmembrane 109 114 non-cytoplasmic 115 134 transmembrane 135 154 cytoplasmic 155 177 transmembrane 178 188 non-cytoplasmic 189 210 transmembrane 211 243 cytoplasmic 244 263 transmembrane 264 280 non-cytoplasmic 281 303 transmembrane 304 311 cytoplasmic 312 331 transmembrane 332 453 non-cytoplasmic 454 477 transmembrane 478 496 cytoplasmic 497 516 transmembrane 517 521 non-cytoplasmic 522 540 transmembrane 541 550 cytoplasmic
Input: >CCNA_01031 MGAKGQAAPAKGRDTMVVGASSLGTVFEWYDFYLYGSLAPIITSHFFSGVNETTGFILAL LAFAAGFAIRPLGALIFGRLGDLWGRKNTFLITMLLMGVSTFVVGLLPSYAQIGVAAPIA LVLMRLVQGLALGGEYGGAATYVAEHAPPGKRGFYTSWIQTTATIGLFLSLAVILVARIQ LGEEAFKAWGWRIPFLVSLLLLGVSLWIRLKLHESPTFERMIAEGKGSKKPLTEAFGNWP NLKIVLLALVGLTMGQAVVWYTGQFYALFFLEKTLKLDGALANTLVAVALLIGTPFFVIC GWLSDKIGRKPIIILGCLLAALTYFPIFKAITTYANPALAKAEATAPVVVTADTATCAFQ FDLIGKAKFNTPCDVAKAYLAKAGVSYSVQAAPAGTPTAVKVGDVTLEGLDSKGATGQAF ADARKAWEADLGAQLKAAGYPAKADAALVNKPAVIGLLALLVIYVTMVYGPIAAMLVELF PTRIRYTAMSLPYHIGNGWFGGFLPTTAFAIVAATGDIYSGLWYPVIIAAITAVVGGLFL KDTRHNRLED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server